Clarivate sells its LS&H segment for $600M to cut debt and boost margins. CLVT stock trades higher as core business focus sharpens.
The divestiture is expected to sharpen Clarivate’s focus on its Academia & Government and Intellectual Property businesses, improve its financial profile, and support debt reduction.
Clarivate Sells Life Sciences & Healthcare Unit
Under the agreement… [1993 chars]
Source: Benzinga | Published: 2026-07-06T08:48:00Z
Credit: Benzinga
